ConductScience.org, home

Paper41018564

Application of nutrition interventions with GLP-1 based therapies: A narrative review of the challenges and solutions.

Fitch A and 2 others. Obes Pillars, 2025. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Application of nutrition interventions with GLP-1 based therapies: A narrative review of the challenges and solutions. Papers, record 41018564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41018564

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Application of nutrition interventions with GLP-1 based therapies: A narrative review of the challenges and solutions.
PubMed
Journal
Obes Pillars
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
4.29, provisional
iCite
Revised in PubMed
2026-09-25
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fitch AAngela
2Gigliotti LLinda
3Bays HEHarold Edward

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References124

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135971075Primary care physicians' knowledge and attitudes about obesity, adherence to treatment guidelines and association with confidence to treat obesity: a Swedish survey study.BMC Prim Care2022https://conductscience.org/library/papers/35971075PubMed
221975647Glucagon-like peptide-1 receptor agonists suppress water intake independent of effects on food intake.Am J Physiol Regul Integr Comp Physiol2011https://conductscience.org/library/papers/21975647PubMed
337689140The effectiveness of medical nutrition therapy provided by a dietitian in adults with prediabetes: a systematic review and meta-analysis.Am J Clin Nutr2023https://conductscience.org/library/papers/37689140PubMed
434775881Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice.Postgrad Med2022https://conductscience.org/library/papers/34775881PubMed
537990727Nonalcoholic fatty liver disease and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022.Obes Pillars2022https://conductscience.org/library/papers/37990727PubMed
638544798Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial.EClinicalMedicine2024https://conductscience.org/library/papers/38544798PubMed
735227529Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement.Clin Nutr2022https://conductscience.org/library/papers/35227529PubMed
838085928Nutrition and physical activity: An Obesity Medicine Association (OMA) Clinical Practice Statement 2022.Obes Pillars2022https://conductscience.org/library/papers/38085928PubMed
937990728Cancer and Obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022.Obes Pillars2022https://conductscience.org/library/papers/37990728PubMed
1032753461Obesity in adults: a clinical practice guideline.CMAJ2020https://conductscience.org/library/papers/32753461PubMed
1139726721Why are we still in need for novel anti-obesity medications?Lancet Reg Health Eur2024https://conductscience.org/library/papers/39726721PubMed
1239386160Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021.EClinicalMedicine2024https://conductscience.org/library/papers/39386160PubMed
1339710882GLP1Ra-based therapies and DXA-acquired musculoskeletal health outcomes: a focused meta-analysis of placebo-controlled trials.Obesity (Silver Spring)2025https://conductscience.org/library/papers/39710882PubMed
1436458843
How might enhanced interprofessional collaboration between primary care physicians and registered dietitian nutritionists impact clinical outcomes related to obesity and associated illnesses? A commentary.
Public Health Nutr2023https://conductscience.org/library/papers/36458843PubMed
1533899338Weight Can't Wait: A Guide to Discussing Obesity and Organizing Treatment in the Primary Care Setting.Obesity (Silver Spring)2021https://conductscience.org/library/papers/33899338PubMed
1637518832
Moving beyond eat less, move more using willpower: Reframing obesity as a chronic disease impact of the 2020 Canadian obesity guidelines reframed narrative on perceptions of self and the patient-provider relationship.
Clin Obes2023https://conductscience.org/library/papers/37518832PubMed
1723225173How do we improve patient compliance and adherence to long-term statin therapy?Curr Atheroscler Rep2013https://conductscience.org/library/papers/23225173PubMed
1839109480The latest evidence and clinical guidelines for use of meal replacements in very-low-calorie diets or low-calorie diets for the treatment of obesity.Diabetes Obes Metab2024https://conductscience.org/library/papers/39109480PubMed
1937661106
The Weight-loss Effect of GLP-1RAs Glucagon-Like Peptide-1 Receptor Agonists in Non-diabetic Individuals with Overweight or Obesity: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials.
Am J Clin Nutr2023https://conductscience.org/library/papers/37661106PubMed
2039582489Recent achievements and future directions of anti-obesity medications.Lancet Reg Health Eur2024https://conductscience.org/library/papers/39582489PubMed

See all 124 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
42796978Foods as Modulators of GLP-1 Secretion.Nutrients2026https://conductscience.org/library/papers/42796978PubMed
42738931Hidden Malnutrition in the GLP-1 Era: Micronutrient Status, Protein Adequacy, and Lean Mass as Emerging Nutritional Considerations-A Narrative Review.Nutrients2026https://conductscience.org/library/papers/42738931PubMed
42738922Lifestyle Medicine as Co-Therapy During Incretin-Based Anti-Obesity Pharmacotherapy: Integrating Physical Activity, Nutrition, and Behavioral Strategies for Long-Term Success.Nutrients2026https://conductscience.org/library/papers/42738922PubMed
42701351The Evolution of Medications for Obesity Management.JGH Open2026https://conductscience.org/library/papers/42701351PubMed
42654223Do Patients Receiving GLP-1 Receptor Agonists for Weight Loss Require Structured Dietetic Care? Lessons from Metabolic and Bariatric Surgery (MBS) Pathways.Nutrients2026https://conductscience.org/library/papers/42654223PubMed
42589975Preventive Strategies to Reduce Sarcopenia Risk During GLP-1-Based Anti-Obesity Therapy.J Clin Med2026https://conductscience.org/library/papers/42589975PubMed
42529748Nutritional considerations for glucagon-like peptide-based therapies: An Asian Indian consensus recommendation.Obes Pillars2026https://conductscience.org/library/papers/42529748PubMed
42382663Micronutrient risk with GLP-1 receptor and dual incretin agonists in obesity: Mechanistic pathways, clinical signals, and a monitoring framework.Obes Pillars2026https://conductscience.org/library/papers/42382663PubMed
42323133Avoiding Malnutrition in the Era of Glucagon-Like Peptide-1 Medications: Emerging Evidence and Opportunities for Integrated Nutrition Care.J Nutr2026https://conductscience.org/library/papers/42323133PubMed
42280393Nutrition-First Support for GLP-1 and Dual Incretin Therapy in Obesity: A Practical Framework for Dietary Management, Symptom Tolerability, and Long-Term Weight Maintenance.Nutrients2026https://conductscience.org/library/papers/42280393PubMed
42210374Shrinking appetites: Will GLP-1 adoption in high-income countries accelerate Big Food's push into low- and middle-income countries?Global Health2026https://conductscience.org/library/papers/42210374PubMed
41815964Nutrition literacy and socio-demographic determinants among Chinese women of childbearing age.Front Public Health2026https://conductscience.org/library/papers/41815964PubMed
41515247Nutrition and Physical Activity in Optimizing Weight Loss and Lean Mass Preservation in the Incretin-Based Medications Era: A Narrative Review.Nutrients2025https://conductscience.org/library/papers/41515247PubMed
41502845Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1 - based therapies: An expert consensus statement using a modified Delphi approach.Obes Pillars2026https://conductscience.org/library/papers/41502845PubMed
41373949Macronutrient, Micronutrient Supplementation and Monitoring for Patients on GLP-1 Agonists: Can We Learn from Metabolic and Bariatric Surgery?Nutrients2025https://conductscience.org/library/papers/41373949PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
GCG2641PubTator's text mininghttps://conductscience.org/library/genes/2641

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41018564

GET https://conductscience.org/api/papers/v1/41018564/references?page=2